Vitamin K

DANDY® CELERY LAUNCHES “NATIONAL CELERY MONTH” SWEEPSTAKES

Retrieved on: 
Monday, March 11, 2024
Marketing, Dandy, Snack, Meal, HERE, Digestion, Vitamin K

Oviedo, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dandy® Produce , a leading grower of fresh celery, radish and corn in the U.S., announces the launch of its “ National Celery Month” Sweepstakes .

Key Points: 
  • Oviedo, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dandy® Produce , a leading grower of fresh celery, radish and corn in the U.S., announces the launch of its “ National Celery Month” Sweepstakes .
  • Three additional winners will be picked to receive a name brand personal blender, $50 online grocery and delivery service gift card as well as more Dandy celery products.
  • The brand will also choose ten winners to receive coupons to enjoy fresh celery even after National Celery Month concludes.
  • “Through this promotion, we hope consumers will celebrate National Celery Month alongside us by incorporating more fresh celery into their springtime snacks and meals.

New Study Adds to the Research Connecting Prunes and Healthier Bones

Retrieved on: 
Thursday, February 15, 2024
Nut, Osteoporosis, Woman, Osteoporosis International, Breakfast, Candy, Radar, Mineral, Learning, CSSD, Cheese, Vitamin K, Nutrient, Pennsylvania State University, Distinguishing, Fruit, Bonci, Eating, Bone density, Dietary supplement

ROSEVILLE, Calif., Feb. 15, 2024 /PRNewswire/ -- A newly published study in Osteoporosis International shows that postmenopausal women who ate prunes daily for a year preserved certain measures of bone structure and estimated bone strength as compared to women who didn't eat prunesi. The study adds to an accelerating body of published research that demonstrates eating prunes daily can help mitigate bone loss in older age.

Key Points: 
  • As women age, their bones can lose density and strength, but studies are showing how eating prunes every day may help make a difference.
  • The study adds to an accelerating body of published research that demonstrates eating prunes daily can help mitigate bone loss in older age.
  • "We've been studying prunes because their combination of nutrients seems to work together for a positive effect on bones.
  • For more information about prune nutrition research and delicious ways to eat prunes more often, visit www.californiaprunes.org .

This February - National Hot Breakfast Month - Start with Tart

Retrieved on: 
Thursday, February 8, 2024
Vitamin C, Nutrient, Vitamin A, Vitamin, Originality, Cooking, Vitamin K, Cereal

WAREHAM, Mass., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Heat things up this winter by beginning your day with a delicious, hot breakfast featuring America's Original Superfruit®.

Key Points: 
  • Heat things up this winter by beginning your day with a delicious, hot breakfast featuring America's Original Superfruit®.
  • WAREHAM, Mass., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Heat things up this winter by beginning your day with a delicious, hot breakfast featuring America's Original Superfruit®.
  • Cooking breakfast with cranberries, aka "starting with tart," is an easy and delicious way to incorporate unique flavor, color, and nutrients into recipes.
  • When searching for new ways to use cranberries, visit http://www.uscranberries.com/recipes , which contains nearly 500 recipes including the following hot breakfast ideas:

BPGbio Presents Updated Phase 2a Clinical Results Demonstrating Benefit of BPM31510 in Combination with Chemotherapy in Pancreatic Cancer at ASCO GI

Retrieved on: 
Thursday, January 18, 2024
Biotechnology, Pharmaceutical, Oncology, Health, Artificial Intelligence, Health Technology, Technology, Clinical Trials, Tumor microenvironment, Patient, Cancer, Sarcoma, Neurology, Glioblastoma, Radiation, Orphan, Division, Food, GBM, Safety, Drug development, Nano, Liver, Toxicity, Phosphorylation, Vitamin K, Pancreatic cancer, Pharmaceutical industry

The multicenter, open-label, non-randomized study aimed to understand the safety and efficacy of BPM31510 delivered intravenously in conjunction with gemcitabine as a second- or third-line therapy for advanced pancreatic cancer.

Key Points: 
  • The multicenter, open-label, non-randomized study aimed to understand the safety and efficacy of BPM31510 delivered intravenously in conjunction with gemcitabine as a second- or third-line therapy for advanced pancreatic cancer.
  • In the phase 2a trial ( NCT02650804 ), 19 patients with refractory pancreatic cancer previously treated with other therapies were enrolled and treated with BPM31510 in combination with gemcitabine.
  • BPM31510 is a proprietary nano-lipid molecule designed to target the tumor microenvironment and induce cancer cell death with minimal toxicity.
  • BPGbio plans to continue to study BPM31510 in pancreatic cancer with a phase 2b study looking at its effect as a first line therapy in combination with gemcitabine.

Prenatal Vitamin Supplements Market to grow by USD 237.81 million from 2022 to 2027; North America to account for 51% of market growth- Technavio

Retrieved on: 
Monday, January 15, 2024
Spina bifida, Dicarboxylic acid, Natural Ingredients, ROW, Mother, Nestlé, Vitamin E, Growth, Capsule, Geography, Vitamin K, Procter, Vitamin A, Pharmavite, Folate, Nutrient, Vitamin D, Supermarket, Iron, Red, Choline, Abbott Laboratories, Biotin, DHA, Pregnancy, Levomefolic acid, Bayer, Child, Anencephaly, Church, Synthetic, Ginger, Riboflavin, Magnesium, Plasma, USD, Free, Zinc, Research, Dietary supplement

NEW YORK, Jan. 15, 2024 /PRNewswire/ -- The prenatal vitamin supplements market is expected to grow by USD 237.81 million from 2022 to 2027.

Key Points: 
  • NEW YORK, Jan. 15, 2024 /PRNewswire/ -- The prenatal vitamin supplements market is expected to grow by USD 237.81 million from 2022 to 2027.
  • This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment.
  • Detailed information on factors that will drive the growth of the prenatal vitamin supplements market between 2022 and 2027.
  • Growth of the prenatal vitamin supplements market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of the prenatal vitamin supplements market players.

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures

Retrieved on: 
Wednesday, January 3, 2024
Phase, Coagulation, Food, Emergency medicine, Risk, Vitamin K, PCC, Hemostasis, FDA, Warfarin, Bleeding, INR, Massachusetts General Hospital, Hospital, Thrombophilia, MD, Doctor of Philosophy, Factor X, Factor IX, Clinical trial, Prothrombin time, Trial of the century, Coagulation factor VII, Octapharma, VKA, Patient, Safety, Harvard Medical School, Thrombin, Pharmaceutical industry

PARAMUS, N.J., Jan. 3, 2024 /PRNewswire/ -- Octapharma USA has announced Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) is now available. The new non-activated four factor prothrombin complex concentrate (4F-PCC), approved by the U.S. Food and Drug Administration (FDA) this summer, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with need for urgent surgery or invasive procedures.

Key Points: 
  • The new non-activated four factor prothrombin complex concentrate (4F-PCC), approved by the U.S. Food and Drug Administration (FDA) this summer, is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with need for urgent surgery or invasive procedures.
  • Octapharma has the Balfaxar® production flexibility to ensure consistent supply for hospitals and medical providers.
  • "Octapharma has the production flexibility to ensure consistent supply for hospitals and medical providers now and in the future.
  • Balfaxar® met the primary endpoint of hemostatic efficacy in patients on a vitamin K antagonist undergoing urgent surgery with significant bleeding risk.

 Your 2024 Veganuary Must-Have Superfood Pantry Staple

Retrieved on: 
Wednesday, January 3, 2024
Copper, Glycemic index, Vitamin K, Vitamin, Vegetable, Mineral, Potassium, Grain boundary strengthening, Taste, Nutrient, Health, Heart, Antioxidant, RDN, Manganese, Boron, Exercise

In recent years, there has been increased popularity in the adoption of plant-based consumption, especially beginning with the month-long commitment of Veganuary.

Key Points: 
  • In recent years, there has been increased popularity in the adoption of plant-based consumption, especially beginning with the month-long commitment of Veganuary.
  • As individuals begin to embark on this journey, California Prunes is the dried fruit superfood you should try integrating as a nutritional powerhouse and vital superfood pantry-staple that can boost your nutrition throughout the month and year ahead.
  • Registered Dietitian Antoine Beauchamp Lepage emphasizes, “adopting a plant-based diet can enhance your energy, focus, weight management, and overall well-being.
  • Not merely a plant-powered snack, California Prunes prove to be a dynamic source of nutrients crucial for any lifestyle.

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Medical Subject Headings, Marketing, Acute coronary syndrome, Thrombolysis, Artery, Moyamoya disease, INN, Risk, ABCD2, ATC, Myocardial infarction, Bleeding, International, Blood, ASA, Brain, NIHSS, Language, Heart, TIA, Vitamin K, Vascular disease, Percutaneous coronary intervention, European Medicines Agency, VKA, Preventive healthcare, Tablet, ADP, Select, Chest pain, Aspirin, Patient, Anatomy, IIA, Atrial fibrillation, Generic drug

Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Clopidogrel Viatris (previously Clopidogrel Taw Pharma), clopidogrel, Date of authorisation: 16/10/2009, Revision: 27, Status: Authorised

BPGbio Announces Phase 2 BPM31510 Glioblastoma Trial-in-Progress Update at Society for Neuro-Oncology Annual Meeting

Retrieved on: 
Thursday, November 16, 2023
Software, Research, Pharmaceutical, Oncology, Technology, Artificial Intelligence, Clinical Trials, Science, Biotechnology, Neurology, FDA, Health, Brain, Safety, Food, GBM, Clinical trial, ESMO, Patient, Vitamin K, Pancreas, Neuro, Stanford University, Glioblastoma, MD, Diagnosis, Survival, Orphan, Society, Pharmaceutical industry

"The information gathered from preclinical and clinical research has offered valuable insights into treatment for GBM, and we eagerly anticipate continuing to advance our discoveries with neoadjuvant BPM31510."

Key Points: 
  • "The information gathered from preclinical and clinical research has offered valuable insights into treatment for GBM, and we eagerly anticipate continuing to advance our discoveries with neoadjuvant BPM31510."
  • The ongoing first-line Phase 2b trial ( NCT04752813 ) follows a successful 104-patient Phase 1a/b clinical trial, which demonstrated both the safety and efficacy of BPM31510.
  • The Phase 1a/b data , which were presented at the European Society for Medical Oncology (ESMO) Annual Meeting in 2019, helped the BPGbio team plan for a Phase 1b trial in advanced GBM patients, where BPM31510 was well tolerated.
  • BPGbio is planning to expand the Phase 2b trial to new clinical sites in the United States and the United Kingdom.

In Honor of World Osteoporosis Day, October 20th, Learn How to Build Better Bones with Sunsweet Amaz!n Prunes

Retrieved on: 
Thursday, October 19, 2023
Science, Research, Meal, Ageing, Vitamin K, Health, International Osteoporosis Foundation, Thought, San Diego State University, Life, Bone health, Copper, Vitamin, Polyphenol, Fracture, Bone fracture, Sunsweet Growers, Manganese, Magnesium, Risk, Mineral, Boron, Dietary fiber, Osteoporosis, Woman, Nutrient, Marketing, Dietary supplement

YUBA CITY, Calif., Oct. 19, 2023 /PRNewswire/ -- Contrary to popular belief, declining bone health is not just a risk for older women. Bone health is important at every age from adolescence to late adulthood for both men and women. On World Osteoporosis Day, Sunsweet Growers wants to help people of all ages feel good about how they can build better bones through their daily snacking and food routines.

Key Points: 
  • YUBA CITY, Calif., Oct. 19, 2023 /PRNewswire/ -- Contrary to popular belief, declining bone health is not just a risk for older women.
  • Bone health is important at every age from adolescence to late adulthood for both men and women.
  • On World Osteoporosis Day, Sunsweet Growers wants to help people of all ages feel good about how they can build better bones through their daily snacking and food routines.
  • Sunsweet is an official supporter of World Osteoporosis Day, organized by the International Osteoporosis Foundation.